Clinical Research
corporate_fare

Enlitisa (Shanghai) Pharmaceutical Co. Ltd.

Address
Room 201 202 203 Building A, Block1 No 800 Qingdai Road

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
2
research centres
public
1
country
person_search
1
investigator

Specializations

Respiratory Fibrosis

Research activity is centered on idiopathic pulmonary fibrosis, with a therapeutic focus on progressive interstitial lung disease and the mechanisms driving lung scarring and fibrotic remodeling.

  • Idiopathic pulmonary fibrosis
  • Interstitial lung disease
  • Pulmonary fibrosis

The sponsor’s clinical interest lies in therapies relevant to chronic deterioration of pulmonary function and the management of fibrotic respiratory disorders.

Clinical Pharmacology

The funded research also reflects an interest in clinical pharmacology, with attention to safety, tolerability, and pharmacokinetics in human subjects.

  • Safety assessment
  • Tolerability
  • Pharmacokinetics

This area supports development of therapies intended for systemic administration and evaluation of their behavior in the body.

Biologic and Injectable Therapies

The sponsor is involved in research on subcutaneous injection approaches and injectable formulations, indicating interest in delivery methods for biologic or other advanced therapeutic candidates.

  • Subcutaneous administration
  • Injectable formulation
  • Advanced therapeutic candidates

These activities align with the development of treatments designed for convenient systemic exposure and controlled delivery.

Sponsored Trials

Trial Name Country Status
Phase 1 Study of TISA-818-Inj-5mg/mL in Idiopathic Pulmonary Fibrosis: Safety, Tolerability, and Pharmacokinetics in Healthy AdultsSweden SwedenNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 2 sites collaborated multiple times

This sponsor has worked with 2 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Respiratory Tract Diseases1 trial
    277 other sponsors

Partnered Research Centres

2 centres
location_city
assignment3
CTC Clinical Trial Consultants AB
Address
Ingang 85 Vaning 2, 751 85 Uppsala
Learn morearrow_forward
location_city
assignment66
CTC Clinical Trial Consultants AB
Address
Dag Hammarskjolds Vag 10b, Uppsala Domkyrkofors., 752 37 Uppsala
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Enlitisa (Shanghai) Pharmaceutical Co. Ltd..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.